156 related articles for article (PubMed ID: 32498876)
21. Therapeutic applications of AS1411 aptamer, an update review.
Yazdian-Robati R; Bayat P; Oroojalian F; Zargari M; Ramezani M; Taghdisi SM; Abnous K
Int J Biol Macromol; 2020 Jul; 155():1420-1431. PubMed ID: 31734366
[TBL] [Abstract][Full Text] [Related]
22. Generation of Rat Monoclonal Antibody for Human Nucleolin.
Nishino Y; Homma T; Ihara KI; Fujii J; Tachibana T; Yokoyama C
Monoclon Antib Immunodiagn Immunother; 2023 Aug; 42(4):145-149. PubMed ID: 37589992
[TBL] [Abstract][Full Text] [Related]
23. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin.
Teng Y; Girvan AC; Casson LK; Pierce WM; Qian M; Thomas SD; Bates PJ
Cancer Res; 2007 Nov; 67(21):10491-500. PubMed ID: 17974993
[TBL] [Abstract][Full Text] [Related]
24. PGRMC1 localization and putative function in the nucleolus of bovine granulosa cells and oocytes.
Terzaghi L; Luciano AM; Dall'Acqua PC; Modina SC; Peluso JJ; Lodde V
Reproduction; 2018 Mar; 155(3):273-282. PubMed ID: 29339453
[TBL] [Abstract][Full Text] [Related]
25. The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cell.
Perrone R; Butovskaya E; Lago S; Garzino-Demo A; Pannecouque C; Palù G; Richter SN
Int J Antimicrob Agents; 2016 Apr; 47(4):311-6. PubMed ID: 27032748
[TBL] [Abstract][Full Text] [Related]
26. Locking up the AS1411 Aptamer with a Flanking Duplex: Towards an Improved Nucleolin-Targeting.
Miranda A; Santos T; Largy E; Cruz C
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33557379
[TBL] [Abstract][Full Text] [Related]
27. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
28. Aptamer-based microcantilever biosensor for ultrasensitive detection of tumor marker nucleolin.
Li H; Bai X; Wang N; Chen X; Li J; Zhang Z; Tang J
Talanta; 2016 Jan; 146():727-31. PubMed ID: 26695322
[TBL] [Abstract][Full Text] [Related]
29. Nanopipette-Based SERS Aptasensor for Subcellular Localization of Cancer Biomarker in Single Cells.
Hanif S; Liu HL; Ahmed SA; Yang JM; Zhou Y; Pang J; Ji LN; Xia XH; Wang K
Anal Chem; 2017 Sep; 89(18):9911-9917. PubMed ID: 28825473
[TBL] [Abstract][Full Text] [Related]
30. Anti-nucleolin aptamer AS1411: an advancing therapeutic.
Van den Avont A; Sharma-Walia N
Front Mol Biosci; 2023; 10():1217769. PubMed ID: 37808518
[TBL] [Abstract][Full Text] [Related]
31. In situ labeling and imaging of cellular protein via a bi-functional anticancer aptamer and its fluorescent ligand.
Ai J; Li T; Li B; Xu Y; Li D; Liu Z; Wang E
Anal Chim Acta; 2012 Sep; 741():93-9. PubMed ID: 22840709
[TBL] [Abstract][Full Text] [Related]
32. Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer.
Rajabnejad SH; Mokhtarzadeh A; Abnous K; Taghdisi SM; Ramezani M; Razavi BM
Drug Dev Ind Pharm; 2018 Jun; 44(6):982-987. PubMed ID: 29325460
[TBL] [Abstract][Full Text] [Related]
33. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells.
Lee KY; Kang H; Ryu SH; Lee DS; Lee JH; Kim S
J Biomed Biotechnol; 2010; 2010():168306. PubMed ID: 20204158
[TBL] [Abstract][Full Text] [Related]
34. RNA G-quadruplex as supramolecular carrier for cancer-selective delivery.
Santos T; Pereira P; Campello MPC; Paulo A; Queiroz JA; Cabrita E; Cruz C
Eur J Pharm Biopharm; 2019 Sep; 142():473-479. PubMed ID: 31325486
[TBL] [Abstract][Full Text] [Related]
35. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
[TBL] [Abstract][Full Text] [Related]
36. A Non-G-Quadruplex DNA Aptamer Targeting NCL for Diagnosis and Therapy in Bladder Cancer.
Liu Y; Hu B; Pei X; Li J; Qi D; Xu Y; Ou H; Wu Y; Xue L; Huang JH; Wu E; Hu X
Adv Healthc Mater; 2023 Aug; 12(20):e2300791. PubMed ID: 37262080
[TBL] [Abstract][Full Text] [Related]
37. Morphometry of nucleoli and expression of nucleolin analyzed by laser scanning cytometry in mitogenically stimulated lymphocytes.
Gorczyca W; Smolewski P; Grabarek J; Ardelt B; Ita M; Melamed MR; Darzynkiewicz Z
Cytometry; 2001 Nov; 45(3):206-13. PubMed ID: 11746089
[TBL] [Abstract][Full Text] [Related]
38. Heterozygous
Sheikh TI; Harripaul R; Vasli N; Ghadami M; Santangelo SL; Ayub M; Sasanfar R; Vincent JB
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052391
[TBL] [Abstract][Full Text] [Related]
39. AS1411-functionalized delivery nanosystems for targeted cancer therapy.
Kozani PS; Kozani PS; Malik MT
Explor Med; 2021; 2():146-166. PubMed ID: 34723284
[TBL] [Abstract][Full Text] [Related]
40. Cell surface nucleolin as a target for anti-cancer therapies.
Koutsioumpa M; Papadimitriou E
Recent Pat Anticancer Drug Discov; 2014 May; 9(2):137-52. PubMed ID: 24251811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
